ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured vs DSP Nifty Healthcare ETF-Direct Plan
NAV, returns and costs — not a recommendation.
 ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured |  DSP Nifty Healthcare ETF-Direct Plan | |
|---|---|---|
| NAV | ₹46.95 | ₹16.5779 |
| NAV date | 2026-08-19 | 2026-08-19 |
| 1 year | +7.93% | -88.75% |
| 3 year (p.a.) | +22.86% | -53.05% |
| 5 year (p.a.) | +16.84% | -53.05% |
| Expense ratio | 0.87% | 0.17% |
| Fund size | ₹6,624.58 Cr | ₹17.23 Cr |
| Risk | Very high | Very high |
| Category | Sectoral Pharma and Healthcare | Etfs |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.